📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Anaphylaxis events following COVID-19 antiviral and neutralising monoclonal antibody treatment for non-hospitalised patients: data from the OpenSAFELY-TPP platform (2023)

First Author: Zheng B

Attributed to: Characterisation, determinants, mechanisms and consequences of the long-term effects of COVID-19: providing the evidence base for health care funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.19704.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.19704.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research